Source: Markets Insider

Sirtex: Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil

The Brazilian National Agency of Supplementary Health recommends SIR-Spheres for the treatment of intermediate- and advanced-stage hepatocellular ...

Read full article »

Sirtex's Competitors | Sirtex's News | Sirtex's Financials

Followers on Owler

269

Est. Annual Revenue

$100-500M

Est. Employees

250-500

CEO

Matt Schmidt

CEO Approval Rating

82/100

Sirtex is a Massachusetts-based medical device company that develops and markets minimally invasive interventional systems for the treatment of liver cancer.